RENAISSANCE TECHNOLOGIES LLC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,030,948

+$5,926,636 QoQ

Shares Held

1,647,800

+12016.2% QoQ

Ownership

2.16%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#14

of 154 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names. FULC ranks #72 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,030,948	1,647,800	+12016.2%	Shares	Sole	2026-08-13
2026-03-31	$104,312	13,600	-21.8%	Shares	Sole	2026-05-14
2025-12-31	$196,794	17,400	-93.0%	Shares	Sole	2026-02-12
2025-09-30	$2,283,440	248,200	+216.2%	Shares	Sole	2025-11-13
2025-06-30	$540,080	78,500	-80.4%	Shares	Sole	2025-08-13
2025-03-31	$1,155,168	401,100	+2925.6%	Shares	Sole	2025-05-14
2024-06-30	$82,193	13,257	-74.9%	Shares	Sole	2024-08-09
2023-09-30	$234,138	52,734	-84.7%	Shares	Sole	2023-11-14
2023-06-30	$1,137,873	344,810	-11.6%	Shares	Sole	2023-08-11
2023-03-31	$1,111,785	390,100	+473.7%	Shares	Sole	2023-05-12
2022-06-30	$333,200	68,000	-49.2%	Shares	Sole	2022-08-12
2021-09-30	$3,777,319	133,900	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.